Explore Our Research
Molecular Pharmacology News
Department of Molecular Pharmacology
Tuesday, May 14, 2013
Dr. Jeffrey Pessin has been awarded $2.5 million from the National Institute of Arthritis and Musculoskeletal and Skin Diseases to study the mechanism of Pompe’s disease.
Resulting from deficiency in an enzyme that breaks down glycogen, a storage form of glucose in the liver and muscle that is the major source of energy for cells, Pompe’s disease can cause fatal heart and lung failure in infants. The process by which cells degrade damaged or unused components and molecules is called macroautophagy and late events in this pathway are damaged in this disease.
The grant will aid Dr. Pessin’s research into the mechanism of muscle degradation in Pompe’s disease and how defects in macroautophagy contribute to this process. Ultimately, Dr. Pessin aims to design nutritional, exercise, and drug therapies that may help restore proper function in this pathway, which also might be used to treat related diseases.
Dr. Pessin is professor of medicine and of molecular pharmacology, director of the Diabetes Research Center, and the Judy R. and Alfred A. Rosenberg Professorial Chair in Diabetes Research.
Giving to Einstein
Graduate Medical Education (G.M.E.)
Graduate Program (Ph.D.)
Master of Science in Bioethics (M.B.E.)
Master of Science in Clinical Research Methods (M.S.)
Medical Program (M.D.)
MSTP Program (M.D. - Ph.D.)
Einstein in the Media
Experts for Media
Social Media Hub
ALBERT EINSTEIN ®
College of Medicine
© 2016 Albert Einstein College of Medicine |
Jack and Pearl Resnick Campus
| 1300 Morris Park Avenue Bronx, NY 10461